 |
Dr. Vincent J. Venditto received training in organic synthesis and vaccine development. He obtained a BS in chemistry from Gettysburg College and then worked for two years at the NCI, NIH as a cancer research trainee before attending graduate school. He obtained a PhD in chemistry from Texas A&M University and worked on vaccine development as an NIH postdoctoral fellow at University of California, San Francisco.
Students and fellows in his lab come from diverse backgrounds with interests in chemistry, biology, drug delivery and experimental therapeutics, but a common goal of exploring novel methods to modulate the immune system. Students and fellows in his lab are encouraged to utilize their skills to advance projects while learning new skills to better appreciate the various aspects of designing novel immunotherapies. You can find out more about Vincent and his research on his webpage Follow Vincent on Twitter @vjvenditto |
Read Vincent’s Emerging Investigator article, ‘In vivo assessment of triazine lipid nanoparticles as transfection agents for plasmid DNA’, DOI: 10.1039/D2BM01289H
Check out our interview with Vincent below:
1. How do you feel about Biomaterials Science as a place to publish research on this topic?
Biomaterials science is a great journal to publish novel lipids for gene delivery. The interdisciplinary nature of our work is highlighted by the broad readership of Biomaterials Science.
2. What aspect of your work are you most excited about at the moment and what do you find most challenging about your research?
The lipids presented in the manuscript demonstrate in vitro and in vivo transfection efficiency, and importantly demonstrates a platform for continued iterative development of novel lipids for improved nucleic acid delivery.
3. In your opinion, what are the most important questions to be asked/answered in this field of research?
How do we improve upon the success achieved with the COVID-19 vaccines?
4. Can you share one piece of career-related advice or wisdom with other early career scientists?
Do what excites you.
